Top entities: Evotec, Dieter Weinand, Wolfgang Hofmann, Duncan McHale, Wesley Wheeler.

What category does this event fall under?

Business — classified as Annual General Meeting.

What is the sentiment of coverage?

Aggregate sentiment score: 10 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

What were the key actions taken?

Evotec elected to Supervisory Board Dieter Weinand · Evotec held Annual General Meeting · Evotec nominated Wolfgang Hofmann

Is this event still developing?

This is an active story, last updated Jun 11, 2026. Coverage continues to evolve.

Business Annual General Meeting

Evotec 2026 AGM Elects New Board

Q: When did this event occur?

First reported Jun 11, 2026; last updated Jun 11, 2026.

Q: What is the market impact?

Direct. The market impact on Evotec is generally neutral to slightly positive, as the company successfully conducted its Annual General Meeting and made changes to its Supervisory Board leadership.

Analysis based on 8 articles · First reported Jun 11, 2026 · Last updated Jun 11, 2026

Sentiment

Attention

Articles

Market Impact

Direct

Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

Market Impact

The market impact on Evotec is generally neutral to slightly positive, as the company successfully conducted its Annual General Meeting and made changes to its Supervisory Board leadership. This demonstrates stable corporate governance, which can reassure investors.

Biotechnology Pharmaceuticals

Event Summary

Evotec SE held its Annual General Meeting on June 11, 2026, where all agenda items were adopted by shareholders. Key outcomes included the election of Dieter Weinand and Dr. Wolfgang Hofmann to the Supervisory Board. Following the meeting, the Supervisory Board appointed Dieter Weinand as its new Chairman, succeeding Prof. Dr. Iris Low-Friedrich. Additionally, Dr. Duncan McHale and Wesley Wheeler were re-elected to the Supervisory Board. The meeting saw 43.10% of Evotec's registered share capital represented.

Key Actions

95 Evotec elected to Supervisory Board Dieter Weinand

90 Evotec held Annual General Meeting

85 Evotec nominated Wolfgang Hofmann

80 Evotec adopted agenda items

70 Evotec re-elected to Supervisory Board Duncan McHale

70 Evotec re-elected to Supervisory Board Wesley Wheeler

Entities Involved

stock

Evotec

Evotec held its Annual General Meeting, where shareholders adopted all agenda items and elected new members to its Supervisory Board, including a new Chairman. This event impacts Evotec's corporate governance and strategic direction.

Importance 100 Sentiment 10

per

Dieter Weinand

Dieter Weinand was newly elected to the Supervisory Board of Evotec and subsequently appointed as its Chairman, succeeding Prof. Dr. Iris Low-Friedrich. This signifies a change in leadership for the Supervisory Board.

Importance 80 Sentiment 20

per

Wolfgang Hofmann

Dr. Wolfgang Hofmann was newly elected to the Supervisory Board of Evotec.

Importance 60 Sentiment 10

per

Duncan McHale

Dr. Duncan McHale was re-elected to the Supervisory Board of Evotec.

Importance 40 Sentiment 5

per

Wesley Wheeler

Wesley Wheeler was re-elected to the Supervisory Board of Evotec.